Start Date
May 31, 2013
Primary Completion Date
August 31, 2013
Study Completion Date
August 31, 2013
GS-5806
Single dose, oral liquid, .5 mL/kg
Placebo
Single dose, oral liquid, .5 mL/kg
Geelong Hospital, Geelong
Monash Medical Center, Clayton
Queensland Children's Medical Research Unit, Herston
Royal Hobart Hospital, Hobart
Women's and Children's Hospital Adelaide, North Adelaide
Royal Children's Hospital, Parkville
Sydney Children's Hospital, Randwick
Princess Margaret Hospital for Children, Subiaco
Westmead Children's Hospital, Westmead
Lead Sponsor
Gilead Sciences
INDUSTRY